The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors interviewed...
Αυτή η ενημέρωση παρέχει μια περίληψη της κατανάλωσης αλκοόλ, της βλάβης από το αλκοόλ, της θεραπείας από το αλκοόλ και των κενών στις γνώσεις σχετικά με τη χρήση αλκοόλ μεταξύ των ΛΟΑΤΚΙ+ ατόμων.
Χρησιμοποιεί το ακρωνύμιο LGBTQ+ για να...
Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) Pride month is celebrated each year during the month of June. Here you can find a list of resources and research on the topic of substance use among the LGBTQ+ community.
1) This repor...
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
Το αλκοόλ και άλλες φαρμακευτικές αγωγές γενικά παρέχονται μόνο σε άτομα, συχνά μακριά από τις οικογένειές τους. Η θεραπεία στοχεύει στη βελτίωση της ευημερίας και στη μείωση των βλαβών της χρήσης ουσιών και οι οικογένειες και οι κοινότητες...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Παρουσιάστηκε από τον Richard Rawson, PhD, Ομότιμο Καθηγητή στο Τμήμα Ψυχιατρικής και Βιοσυμπεριφορικής Επιστήμης της Ιατρικής Σχολής του UCLA και Καθηγητή Έρευνας στο Πανεπιστήμιο του Βερμόντ, αυτή η παρουσίαση παρείχε μια επισκόπηση των...
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network has been launched!
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
Οι αγορές εξαϋδροκανναβινόλης (HHC) και συναφών ημισυνθετικών κανναβινοειδών (SSC) είναι ταχέως εξελισσόμενες περιοχές με σχετικά περιορισμένες διαθέσιμες πληροφορίες.
Η ευρωπαϊκή κατάσταση που παρουσιάζεται στο τμήμα 1 μπορεί να...
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past-year...